We Think You Should Be Aware Of Some Concerning Factors In Eastman Chemical's (NYSE:EMN) Earnings
We Think You Should Be Aware Of Some Concerning Factors In Eastman Chemical's (NYSE:EMN) Earnings
Eastman Chemical Company's (NYSE:EMN) robust recent earnings didn't do much to move the stock. However the statutory profit number doesn't tell the whole story, and we have found some factors which might be of concern to shareholders.
伊士曼化学公司(纽约证券交易所代码:EMN)近期的强劲收益并没有对该股产生太大影响。但是,法定利润数字并不能说明全部情况,我们发现了一些可能引起股东关注的因素。
The Impact Of Unusual Items On Profit
不寻常物品对利润的影响
To properly understand Eastman Chemical's profit results, we need to consider the US$271m gain attributed to unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And, after all, that's exactly what the accounting terminology implies. If Eastman Chemical doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.
为了正确了解伊士曼化工的利润业绩,我们需要考虑不寻常项目带来的2.71亿美元收益。虽然获得更高的利润总是件好事,但来自不寻常物品的巨额捐款有时会抑制我们的热情。我们统计了全球大多数上市公司的数字,不寻常的物品在自然界中很常见。而且,毕竟,这正是会计术语的含义。如果伊士曼化学认为这一贡献不会重演,那么在其他条件相同的情况下,我们预计其本年度的利润将下降。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
这可能会让你想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看根据他们的估计描绘未来盈利能力的交互式图表。
Our Take On Eastman Chemical's Profit Performance
我们对伊士曼化学利润表现的看法
Arguably, Eastman Chemical's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Eastman Chemical's true underlying earnings power is actually less than its statutory profit. But the good news is that its EPS growth over the last three years has been very impressive. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Eastman Chemical as a business, it's important to be aware of any risks it's facing. You'd be interested to know, that we found 2 warning signs for Eastman Chemical and you'll want to know about them.
可以说,伊士曼化工的法定收益被提高利润的不寻常项目所扭曲。因此,在我们看来,伊士曼化学的真正潜在盈利能力实际上可能低于其法定利润。但好消息是,其在过去三年中的每股收益增长非常令人印象深刻。本文的目标是评估我们在多大程度上可以依靠法定收益来反映公司的潜力,但还有很多需要考虑的地方。如果您想进一步了解伊士曼化学作为一家企业,请务必了解其面临的任何风险。你可能会有兴趣知道,我们发现了两个伊士曼化学的警告标志,你会想知道的。
This note has only looked at a single factor that sheds light on the nature of Eastman Chemical's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.
这份报告只研究了揭示伊士曼化学利润性质的单一因素。但是,如果你能够将注意力集中在细节上,总会有更多的事情需要发现。有些人认为高股本回报率是优质业务的好兆头。因此,你可能希望看到这份免费收藏的拥有高股本回报率的公司,或者这份内部人士正在购买的股票清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。